COMBINATION OF A BCL-2 INHIBITOR AND A BROMODOMAIN INHIBITOR FOR TREATING CANCER
申请人:Gilead Sciences, Inc.
公开号:US20180133212A1
公开(公告)日:2018-05-17
Provided herein are methods and compositions for the treatment of cancer. In particular, the methods include administration of a Bcl-2 inhibitor and a BET inhibitor.